Keep track of the latest Top 50 Pharma insights from healthcare professionals

Discover what online healthcare professionals (eHCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are eHCPs responding to drug launch news? How are eHCPs talking about or engaging with the Top 50 pharma companies on social media?

Top 50 Pharma Tracker Updates

Read through the latest trackers which cover a month period of HCP conversation online.

03.05.2024 | Article

Top 50 Pharma Tracker: eHCPs Thank Pharma for Supporting American Congresses

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

02.04.2024 | Article

Top 50 Pharma Tracker: Pharma supported #TumorBoardTuesday is a hit for eHCPs

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

12.03.2024 | Article

Top 50 Pharma Tracker: Pfizer’s Super Bowl advert is a touchdown for eHCPs

Discover what healthcare professionals (HCPs) think about pharma companies

By Aman Jandu

01.02.2024 | Article

Top 50 Pharma Tracker: eHCPs share pharma sponsored webinar, nurse guidelines and recent approvals

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

02.01.2024 | Article

Top 50 Pharma Tracker: Year ends on a positive note for eHCPs with SABCS highlights

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

02.12.2023 | Article

Top 50 Pharma Tracker: eHCPs share news of Eli Lilly’s Zepbound FDA approval

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

02.11.2023 | Article

Top 50 Pharma Tracker: Novavax FDA approval received positively by eHCPs

Pfizer, Moderna, Novavax, Johnson & Johnson, and AstraZeneca were the most discussed by HCPs

By Aman Jandu

01.10.2023 | Article

Top 50 Pharma Tracker: eHCPs celebrate vaccine data from Novavax and Moderna approval

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

01.09.2023 | Article

Top 50 Pharma Tracker: Novo Nordisk’s semaglutide trial gets praise from HCPs

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

11.08.2023 | Article

Top 50 Pharma Tracker: eHCP concern about drug shortages after tornado damages Pfizer facility

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

02.07.2023 | Article

Top 50 Pharma Tracker: eHCPs approve of new pharma trial data at ASCO 2023

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

12.06.2023 | Article

Top 50 Pharma tracker review: The importance of knowing what HCPs think.

Looking at the corporate reputation of the Top 50 pharma companies over the past year

By Francesca Gan

01.06.2023 | Article

Top 50 Pharma Tracker: eHCPs commend pharma companies for their contributions to local communities

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Imma Tinat

01.05.2023 | Article

Top 50 Pharma Tracker: eHCPs applaud pharma collaborating with one another

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Imma Tinat

01.04.2023 | Article

Top 50 Pharma Tracker: eHCPs celebrate Eli Lilly for capping the cost of insulin

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Imma Tinat

05.01.2023 | Article

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma vaccine and immunotherapy

The 5 companies mentioned the most by HCPs were Pfizer, Moderna, Johnson & Johnson....

By Francesca Gan

18.12.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

In Nov 2022 there was a 22% decrease in HCP pharma mentions from the previous month

By Francesca Gan

14.11.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

The FDA granted emergency use of Pfizer and Moderna's bivalent vaccine in children

By Francesca Gan

05.10.2022 | Article

Top 50 Pharma Tracker: Bivalent vaccine data and new treatments drive HCP conversation

The latest developments in the Top 50 tracker saw GSK jump back amongst the Top 5.

By Francesca Gan and Chawanzi Chintu

05.09.2022 | Article

Top 50 Pharma Tracker: HCPs discuss bivalent vaccine approval in the UK and advances in obesity treatment.

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

04.08.2022 | Article

Top 50 Pharma Tracker: HCPs continue to discuss Moderna’s COVID-19 vaccine but mentions of Pfizer dramatically decrease

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

02.07.2022 | Article

Top 50 Pharma Tracker: HCPs share mixed opinions on COVID-19 vaccines and treatment data

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

06.06.2022 | Article

Top 50 Pharma Tracker: HCPs discuss Pfizer vaccine documents and share opinions on COVID-19 vaccine efficacy.

Conversations continued to revolve around COVID-19 vaccine efficacy with HCPs sharing...

By Francesca Gan and Chawanzi Chintu

05.05.2022 | Article

Top 50 Pharma Tracker: HCPs celebrate the success of Lilly’s tirzepatide for obesity and discuss COVID-19 vaccine efficacy

Notably this month, HCPs celebrated the efficacy of Lilly’s tirzepatide for obesity patients

By Francesca Gan and Chawanzi Chintu

13.04.2022 | Article

Top 50 Pharma Tracker: HCPs compare immune responses of T cell, B cell, and Antibodies to different COVID-19 vaccines.

Conversations still largely revolved around vaccine efficacy, with HCPs sharing various...

By Francesca Gan and Chawanzi Chintu

11.03.2022 | Article

Top 50 Pharma Tracker: HCPs discuss Healthcare inequity and vaccination of under 5 year olds

HCPs largely discussed healthcare inequity, comparing the revenue of pharmaceutical...

By Francesca Gan and Chawanzi Chintu

08.02.2022 | Article

Top 50 Pharma Tracker: HCPs get political when discussing Regeneron’s COVID-19 treatment

HCPs get political when discussing Regeneron’s COVID-19 treatment

By Francesca Gan and Chawanzi Chintu

11.01.2022 | Article

Top 50 Pharma Tracker: Omicron variant dominates HCP conversation in December 2021

Discover what healthcare professionals (HCPs) are saying about the Omicron variant

By Francesca Gan and Chawanzi Chintu

01.12.2021 | Article

Top 50 Pharma Tracker: HCPs discuss trial data of Pfizer’s COVID-19 booster vaccine and oral treatment

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

Header image for Top 50 Pharma tracker

01.11.2021 | Article

Top 50 Pharma Tracker: Pfizer most discussed company with booster and children’s COVID-19 jabs

Discover what healthcare professionals (HCPs) think about children's COVID-19 jabs

By Mary Kangley

02.04.2021 | Article

Top 50 Pharma Tracker: Oxford-AstraZeneca vaccine provokes HCP conversation as they discuss blood clots as a side effect.

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Maria Aguirre

02.03.2021 | Article

Top 50 Pharma Tracker: J&J FDA approval of single-dose vaccine stirs HCP conversations

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Maria Aguirre

02.02.2021 | Article

Top 50 Pharma Tracker: J&J new vaccine data drives increase in company posts online

Discover what healthcare professionals (HCPs) think about Top pharmaceutical companies

By Maria Aguirre

01.01.2021 | Article

Top 50 Pharma Tracker: COVID-19 makes up 84% of total conversation

Discover what healthcare professionals (HCPs) think about Top 50 Pharmaceutical companies

By Maria Aguirre

02.12.2020 | Article

Top 50 Pharma Tracker: Vaccine success dwarfs all other conversation

Discover what healthcare professionals (HCPs) think about Top 50 Pharmaceutical companies

By Mary Kangley

02.11.2020 | Article

Top 50 Pharma Tracker: Regeneron tops list due to high profile COVID-19 treatment conversation

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

01.10.2020 | Article

Top 50 Pharma Tracker: AstraZeneca’s vaccine trial safety discussed but transparency is celebrated.

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

02.09.2020 | Article

Top 50 Pharma Tracker: HCPs discuss AstraZeneca more than Gilead for first time since pandemic

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

03.08.2020 | Article

Top 50 Pharma Tracker: COVID-19 candidates take over all HCP conversation

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

30.07.2020 | Article

Primed for digital transformation in 2020: Learnings from HCP online engagement with Top 50 Pharma

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

Top 50 Pharma Tracker: HCPs respond to COVID-19 treatment options

01.07.2020 | Article

Top 50 Pharma Tracker: HCPs respond to COVID-19 treatment options

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

Top 50 Pharma Tracker: HCPs track Pharma Covid-19 developments online

05.06.2020 | Article

Top 50 Pharma Tracker: HCPs track Pharma Covid-19 developments online

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

Top 50 Pharma Tracker: HCPs respond to Pharma Covid-19 activity

05.05.2020 | Article

Top 50 Pharma Tracker: HCPs respond to Pharma Covid-19 activity

Top 50 Pharma Tracker: HCPs respond to Pharma Covid-19 activity

By Mary Kangley

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

01.04.2020 | Article

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

By Mary Kangley

Top 50 Pharma Tracker: HCPs discuss Gilead, Eisai and Merck & Co’s trial results

06.03.2020 | Article

Top 50 Pharma Tracker: HCPs discuss Gilead, Eisai and Merck & Co’s trial results

Top 50 Pharma Tracker: HCPs discuss Gilead, Eisai and Merck & Co’s trial results

By Mary Kangley

Top 50 Pharma Tracker: New year begins with failed trials and successful podcast launch

06.02.2020 | Article

Top 50 Pharma Tracker: New year begins with failed trials and successful podcast launch

Top 50 Pharma Tracker: New year begins with failed trials and successful podcast launch

By Mary Kangley

Top 50 Pharma Tracker: @Novartis most mentioned Twitter account for second month

06.01.2020 | Article

Top 50 Pharma Tracker: @Novartis most mentioned Twitter account for second month

Top 50 Pharma Tracker: @Novartis most mentioned Twitter account for second month

By Mary Kangley

Top 50 Pharma tracker: Gilead into Top 5 after price discrepancy

03.12.2019 | Article

Top 50 Pharma tracker: Gilead into Top 5 after price discrepancy

Top 50 Pharma tracker: Gilead into Top 5 after price discrepancy

By Mary Kangley

HCPs engage with Top 50 pharma around good and bad news

12.11.2019 | Article

HCPs engage with Top 50 pharma around good and bad news

HCPs engage with Top 50 pharma around good and bad news

By Mary Kangley

HCPs engaged meaningfully with Top 50 Pharma on Twitter in September 2019

10.10.2019 | Article

HCPs engaged meaningfully with Top 50 Pharma on Twitter in September 2019

HCPs engaged meaningfully with Top 50 Pharma on Twitter in September 2019

By Mary Kangley

#WhatHCPsThink about the top 50 pharmaceutical companies on Twitter

18.09.2019 | Article

#WhatHCPsThink about the top 50 pharmaceutical companies on Twitter

In August 2019, CREATION Pinpoint® identified 8,289 healthcare professional (HCP) authored

By Mary Kangley

Interested in some of our other Trackers?

Check out our Product Launch tracker for key insights about pharmaceutical products and their manufacturers or if you’re interested in updates related to respiratory diseases and developments, see our Respiratory Tracker page.